University of Pennsylvania Office of Technology Transfer

University of Pennsylvania Office of Technology Transfer
Name	Office of Technology Transfer
Parent institution	University of Pennsylvania
Established	1970s
Location	Philadelphia, Pennsylvania
Director	(varies)
Website	(official site)

University of Pennsylvania Office of Technology Transfer

The Office of Technology Transfer facilitates the translation of research from the University of Pennsylvania into commercial applications and public benefit, operating at the intersection of Penn Medicine, Perelman School of Medicine, School of Engineering and Applied Science, Wharton School of the University of Pennsylvania and other institutional units. It works with inventors associated with Annenberg School for Communication, School of Arts and Sciences, Towne Scientific, Bioengineering, and laboratories linked to Wistar Institute, Children's Hospital of Philadelphia, and collaborative centers tied to DARPA, National Institutes of Health, and National Science Foundation. The office engages with regional partners such as University City Science Center, Ben Franklin Technology Partners of Southeastern Pennsylvania, Philadelphia Industrial Development Corporation, and national entities including U.S. Patent and Trademark Office, Bayh–Dole Act, and private investors from Sequoia Capital and Third Rock Ventures.

History

The office traces its origins to technology transfer movements in the 1970s, paralleling shifts after the Bayh–Dole Act and contemporaneous with activities at Massachusetts Institute of Technology, Stanford University, and Columbia University. Early collaborations connected researchers from Perelman School of Medicine with partners at Eli Lilly and Company, Pfizer, and federal programs at the National Institutes of Health and Department of Defense. Over subsequent decades the office negotiated licensing with firms such as GlaxoSmithKline, Johnson & Johnson, and startups spun out in partnership with incubators like Y Combinator and regional accelerators associated with Ben Franklin Technology Partners of Southeastern Pennsylvania. Institutional milestones included expanded patent portfolios during the biotech boom alongside inventions from researchers linked to Howard Hughes Medical Institute, Wistar Institute, and cross-disciplinary labs with DARPA funding.

Mission and Governance

The office's mission aligns with directives from the University of Pennsylvania governing bodies, including coordination with the Board of Trustees of the University of Pennsylvania, Provost of the University of Pennsylvania, and deans of Perelman School of Medicine and the School of Engineering and Applied Science. Its governance structure interfaces with counsel experienced in matters related to the U.S. Patent and Trademark Office, Federal Bayh–Dole Act, and institutional policies mirrored at Harvard University, Yale University, and Princeton University. Leadership typically comprises technology licensors, legal counsel with backgrounds at firms such as WilmerHale, Skadden, Arps, Slate, Meagher & Flom, and administrators experienced with grants from the National Science Foundation and contracts with Department of Defense agencies.

Services and Programs

The office provides services including invention disclosure management, patent prosecution, licensing negotiation, material transfer agreements, and templates for sponsored research agreements used by entities like NIH, NSF, and DARPA. Programs include inventor training modeled on practices from Stanford University's Office of Technology Licensing, entrepreneurship workshops in partnership with the Wharton School of the University of Pennsylvania, and accelerator linkages with Dreamit Ventures and Y Combinator. It administers transactional workflows similar to those at Columbia Technology Ventures and assists researchers from units such as Perelman School of Medicine, School of Veterinary Medicine, and School of Arts and Sciences in navigating collaborations with industry partners including Pfizer, Merck, and Roche.

Intellectual Property and Patent Policy

IP policy follows principles established under the Bayh–Dole Act and practices aligning with policies at MIT, Harvard University, and Johns Hopkins University. The office manages patent prosecution before the U.S. Patent and Trademark Office and coordinates foreign filings in jurisdictions handled by counterparts at the European Patent Office and national patent offices. It negotiates rights for sponsored research with agencies such as NIH, NSF, and DARPA, and structures agreements accommodating venture capital firms including Sequoia Capital and corporate partners like Johnson & Johnson and GlaxoSmithKline.

Licensing and Commercialization

Licensing activities have led to partnerships with pharmaceutical companies such as Pfizer and Eli Lilly and Company, biotech firms including Genentech and Amgen, and medical device companies like Medtronic. The office negotiates exclusive and non-exclusive licenses, option agreements, and equity arrangements with startups backed by investors such as Third Rock Ventures and Flagship Pioneering. Commercialization strategies mirror those used at peer institutions including Stanford University, MIT, and Columbia University, and involve technology transfer offices across networks like the Association of University Technology Managers.

Startups and Entrepreneurship Support

Support for startup formation includes assistance with company formation, seed financing connections to angels and firms such as Sequoia Capital and Andreessen Horowitz, and mentoring programs with the Wharton School of the University of Pennsylvania and Pennovation Center. The office works alongside incubators like Dreamit Ventures and accelerators such as Y Combinator to shepherd ventures emerging from research in bioengineering, nanotechnology, and computer science. Notable entrepreneurial collaborations have involved faculty affiliated with Perelman School of Medicine, School of Engineering and Applied Science, and translational programs linked to Wistar Institute and Children's Hospital of Philadelphia.

Notable Technologies and Impact

Technologies commercialized include therapeutics and diagnostics with ties to companies such as GlaxoSmithKline, Pfizer, and Genentech; medical devices developed in collaboration with Medtronic and Boston Scientific; and software and analytics platforms influenced by research at the Wharton School of the University of Pennsylvania and the School of Engineering and Applied Science. Impact metrics reflect licensing revenue streams comparable to outcomes reported by Stanford University and Massachusetts Institute of Technology, startup creation parallel to trends at Yale University and Harvard University, and translational outcomes supported by grants from NIH and commercialization partnerships with firms such as Eli Lilly and Company. The office's activities contribute to regional innovation ecosystems involving the University City Science Center, Ben Franklin Technology Partners of Southeastern Pennsylvania, and municipal stakeholders like the Philadelphia Industrial Development Corporation.

Category:University of Pennsylvania Category:Technology transfer offices